Cisplatin, Gemcitabine, Interferon Alfa, and Hyperthermia in Treating Patients With Advanced Cancer

NCT00004063 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Unspecified Adult Solid Tumor, Protocol Specific

Interventions

BIOLOGICAL: recombinant interferon alfa
DRUG: cisplatin
DRUG: gemcitabine hydrochloride
PROCEDURE: hyperthermia treatment

Sponsor

The University of Texas Health Science Center, Houston